Peer Review History
| Original SubmissionJuly 20, 2021 |
|---|
|
PONE-D-21-23594BODY COMPOSITION, PHYSICAL FITNESS AND PHYSICAL ACTIVITY IN MOZAMBICAN CHILDREN AND ADOLESCENTS WITH HIVPLOS ONE Dear Dr. Chirindza, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 27 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Giordano Madeddu Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service. Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services. If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free. Upon resubmission, please provide the following: The name of the colleague or the details of the professional service that edited your manuscript A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file) A clean copy of the edited manuscript (uploaded as the new *manuscript* file) 3. In your Methods section, please provide a justification for the sample size used in your study, including any relevant power calculations (if applicable). 4. Thank you for stating the following financial disclosure: "We have not any grant, sponsorship or support from our institution to pay the publication we are requesting fee waive for the publication" At this time, please address the following queries: a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution. b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” c) If any authors received a salary from any of your funders, please state which authors and which funders. d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 5. Thank you for stating the following in your Competing Interests section: "All data generated or analyzed during this study are included in this published article." Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now This information should be included in your cover letter; we will change the online submission form on your behalf. 6. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 7. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 8. Please upload a new copy of Figure 1 as the detail is not clear. Please follow the link for more information: https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/" https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/ [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: General comment: The present study has a relevant theme and based on the findings of this study, health promotion actions can be better designed for children and adolescents with HIV. Comment: In general the introduction is well written. Only at the end, the authors could add how the investigation of this information could help health professionals. Comment: In the methodology, I suggest to the authors the inclusion of the sample size calculation, even if it is performed a posteriori. Comment: In the methodology explain better how the children and adolescents who took part in the study were recruited. Comment: In the statistical analysis, shouldn't sex be considered as an adjustment in ANCOVA? Comment: When comparing variables between boys and girls, enter the P values showing whether there are significant differences. “Most of the studies in the literature reveal identical results. Dos Santos [44] evaluated 63 Brazilian children and adolescents and found that both abdominal muscle strength and flexibility presented values below the cutoff point in both sexes. Barros et al. [49] studied the muscular strength of 33 Brazilian children of both sexes, aged between 7 and 12 years, all with HIV on ART, and observed that the scores in the neuromotor tests were below the normal range, as well as in relation to the group of children who did not have the virus, even when compared by sex, wich agree with the results of the present study.” Comment: What would be the reasons? The authors seek to discuss the possible mechanisms. “In a cross-sectional study Martins et al. [37] done with a sample of 57 Brazilian adolescents of both sexes between 10 and 15 years, with HIV and a control group of the same size and age and sexual level, using the physical activity questionnaire (PAQ-C). It was observed that adolescents with HIV had lower scores of physical activity when compared to their peers considered healthy.” Comment: Why does this happen? What are the possible differences? Comment: In the discussion, the authors make a series of important comparisons, but there is still a need to better discuss the reason for the differences or similarities of these comparisons. Comment: A limitation that must be considered is the fact that the sample was by convenience (which does not diminish the importance of the study). Comment: After the limitation paragraph, insert the study's strengths paragraph. Comment: What are the practical applications of this study. How can this information help health professionals who care for children and adolescents with HIV? Reviewer #2: The authors presented an interesting study about body composition and physical activity in Mozambican children and adolescents. Although the article is well written and shows interesting conclusions, it fails to provide innovations. Per the authors admission, "This finding seems to be common to many studies, which state that children and adolescents living with HIV tend to be smaller, have lower body weight and enter puberty later compared to their apparently healthy peers". Moreover, we found some serious problems the authors should address: 1) METHODS a) "The ART regimen in use and the viral load were not taken into account for this study" We find that this choice is problematic and limits the validity of the results of the study for several reasons. First of all, it is known that different drugs have different effects on metabolism, and especially lipid metabolism. Moreover, a persistent high level of plasma viral load leads to poor growth rates, due to persisting inflammation. In addition, low level viremia has been also related to persisting high levels of inflammation. Therefore, we find that not considering actual ART regimen, past ART regimens (if any), time spent on ART regiment (present and past), and pVL makes the results of this study unreliable and non-reproducible. 2) RESULTS a) "Descriptive results (n, mean +/- sd)" Were the quantitative variables normally distributed? If not, "median (IQR)" should be used to summarize the variables. Reviewer #3: Comments to the authors PONE-D-21-23594 Title of the paper: Body composition, physical fitness and physical activity in children and adolescents with HIV. The author(s) presented an interesting cross-sectional data on “Body composition, physical fitness and physical activity in children and adolescents with HIV from Mozambique”. There are some minor points which have to be considered in the manuscript. Generally, the authors stated that ‘the adolescents and children with’; and this sounds not good and need to rephrased to include the word ‘living’ with, and this need to be addressed throughout the manuscript. Title: The title is missing the inclusion of the word ‘living’ between the words ‘…adolescents .. and … with ..’. so that it reads as ‘Body composition, physical fitness and physical activity in children and adolescents living with HIV’. Abstract: In the background and methods section first sentence, the authors are advised to reconsider the inclusion of the word ‘living’ as per comments above. In the second sentence the authors wrote a prefix for physical in capital letter and it is inconsistent with others, a clarification will be helpful. The first conclusion sentence need to be rephrased, and it can be rephrased as ‘The subjects participants in the study living with HIV and undergoing ART had impaired growth………….’ Introduction Can the authors clarify why the prefix for ‘development’ the sentence reading as ‘The Development of children…..’ written in capital letter. In strengthening the arguments in the second paragraph of the introduction it would have been good if the authors could have considered a systematic review and meta-analysis by Rafaela Catherine da Silva Cunha de Medeiros and colleagues as published in 2021. Methods Can the authors clarify the how the contacts were done in the statement ‘Subjects were selected by contacts made with those who attended specific health care centers for children and adolescents with HIV in Maputo’ consideration the issues of stigmatisation amongst and ethical issues. It will helpful for the paper if the author could give a full description of the care centers settings in Mozambique. Also, the authors should provide the ethical approval number of the study given the vulnerability of the subjects participants in the study. Under statistical analysis, sentence reading as ‘the proportion……’; an inconsistency has been observed in terms of the writing of sentences. As such corrections is required. Spelling mistake for the word ‘same’ in the sentence reading as ‘To compare with non-HIV ± Mozambican peers of the some age and gender…..’. The authors are advised to make corrections. Results In table 1 and its text the authors for the first time are presented the distributions of the participants according to urban and rural settings of which such description is not explicit in the description of the participants in the methods. The authors should provide the description of their subjects participants in the methods section. As indicated in Table 4 that it is about comparison of the HIV± and HIV-; can the authors clarify the distribution of this groups from their 79 included participants because it is unclear. Such clarification will helpful in understanding the subsequent analysis. Discussion In line with the comments regarding comparison between HIV± and HIV-, the major findings outlined in the first paragraph remain sketchy until a clarification is made about the distribution of the participants in accordance with this distribution. Second paragraph, the name of the country Mozambique is written in small letter, as such corrections is needed. Page 18, sentence reading as ‘This was consistent with few exception’. What are those exceptions, because this sentence seems lacking supporting statements. Clarification is required. Under the subheading ‘Physical fitness’; 2nd paragraph sentence reading as ‘…..compared by sex, wich agree with the results of the present study.’ There is a spelling mistake for the word ‘which’; and corrections is needed. The described limitations are without a proper link with the results and how they affected the current findings. As such, a more concise clarification regarding the limitations is required. References Generally, there are inconsistence references whereby some date are written in brackets (i.e. Ref numbers; 7;28;48; 55) and others not or just after the authors; and or at the end of the journal name. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
BODY COMPOSITION, PHYSICAL FITNESS AND PHYSICAL ACTIVITY IN MOZAMBICAN CHILDREN AND ADOLESCENTS LIVING WITH HIV PONE-D-21-23594R1 Dear Dr. Chirindza, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Diego Augusto Santos Silva, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors responded point by point to all my comments, as well as added the suggestions in the text. So I have no further comments to make. Reviewer #3: I am satisfied with the revised manuscript as the authors addressed all the comments which was raised from the initial review. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Diego G.D. Christofaro- São Paulo State University (UNESP) Reviewer #3: No ********** |
| Formally Accepted |
|
PONE-D-21-23594R1 Body composition, physical fitness and physical activity in Mozambican children and adolescents living with HIV Dear Dr. Chirindza: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Diego Augusto Santos Silva Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .